| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9149(92)91215-P |
| P698 | PubMed publication ID | 1585854 |
| P2093 | author name string | G. Sigurdsson | |
| H. Sigvaldason | |||
| G. Thorgeirsson | |||
| N. Sigfusson | |||
| A. Baldursdottir | |||
| U. Agnarsson | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 1251-1254 | |
| P577 | publication date | 1992-05-01 | |
| 1992-05-15 | |||
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men | |
| P478 | volume | 69 |
| Q37288388 | A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias. |
| Q53154011 | A unique pattern of apo(a) polymorphism in an isolated east Greenlandic Inuit (Eskimo) population. |
| Q77340451 | Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan |
| Q72662515 | Apolipoproteins and ischaemic heart disease: implications for screening |
| Q73688002 | Are lipid-dependent indicators of cardiovascular risk affected by renal transplantation? |
| Q77958706 | Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age |
| Q41732277 | Biogenesis of lipoprotein(a) in human and animal hepatocytes |
| Q61684253 | Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS) |
| Q33614415 | Comparative study of risk factors in patients undergoing coronary or femoropopliteal artery bypass grafting |
| Q36412236 | Correlation analysis between serum lipoprotein (a) and the incidence of aortic valve sclerosis |
| Q64930565 | Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). |
| Q40802371 | Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease |
| Q43749764 | Evaluation of a fully-automated particle-enhanced turbidimetric immunoassay for the measurement of plasma lipoprotein(a). population-based reference values in an area with low incidence of cardiovascular disease. |
| Q74595429 | Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels |
| Q73712793 | HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemia |
| Q35371909 | High apolipoprotein AI concentrations are associated with lower mortality and myocardial infarction five years after coronary artery bypass graft surgery |
| Q71125983 | Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men |
| Q44268486 | Hypertriglyceridemia as a cardiovascular risk factor |
| Q74314734 | Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study |
| Q41719630 | Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women |
| Q34647728 | Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study |
| Q40964818 | Lipoprotein (a). |
| Q77896432 | Lipoprotein(a) as a risk factor for coronary artery disease |
| Q43762325 | Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia |
| Q51587807 | Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (the Québec Cardiovascular Study) |
| Q21284797 | Lipoprotein(a) in cardiovascular diseases |
| Q40937490 | Lipoprotein(a) in renal disease |
| Q77714432 | Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study |
| Q24629580 | Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events |
| Q35799761 | Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis. |
| Q37140097 | Novel markers of inflammation in atherosclerosis. |
| Q72669616 | Predicting coronary heart disease |
| Q71270553 | Predictive value of lipid profile for salutary coronary angiographic changes in patients on a low-fat diet and physical exercise program |
| Q31879006 | Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial |
| Q92987338 | Reference Materials for the Standardization of the Apolipoproteins A-I and B, and Lipoprotein(a) |
| Q73318670 | Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men |
| Q74147884 | Relation between lipoprotein (a) and in vitro oxidation of apolipoprotein B-containing lipoproteins |
| Q33786237 | Screening for cardiovascular disease. Concepts, conflicts, and consensus |
| Q38298100 | Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism |
| Q78004675 | Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study |
| Q48751421 | Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. |
| Q31129827 | The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases |
| Q40437279 | The evaluation of carotid intima-media thickness in children with familial Mediterranean fever |
| Q34154477 | The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate |
| Q43748761 | Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women |
| Q48033046 | Use of apolipoprotein parameters and endpoints in drug development and approval processes |
Search more.